Minimally invasive pelvic exenteration for gynaecological malignancies: the challenge of patients’ selection
N. Bizzarri1, V. Chiantera2, M. Loverro1, A. Ercoli3, G. Vizzielli4, G. Scambia1
1 UOC Ginecologia Oncologica, Dipartimento di scienze della salute della donna, del bambino e di sanità pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy
2 Unit of Gynecologic Oncology, ARNAS “Civico – Di Cristina – Benfratelli”, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy
3 Department of Human Pathology of Adult and Childhood “G. Barresi”, Unit of Gynecology and Obstetrics, University of Messina, Messina, Italy
4 Department of Obstetrics, Gynecology, and Pediatrics, Obstetrics and Gynecology Unit, Udine University Hospital, DAME, Udine, Italy.
Published online: Sep 24 2023
https://doi.org/10.52054/FVVO.15.3.084
Pelvic exenteration is a radical procedure representing a salvage option in patients with recurrent or persistent
gynaecological malignancies. It can be performed with an open or minimally invasive approach. Different
studies have demonstrated optimal peri-operative outcomes of minimally invasive pelvic exenteration with
no survival difference when compared with an open approach. In this article, we discuss the importance and
the challenge of patient selection for pelvic exenteration and more specifically for minimally invasive pelvic
exenteration.
